BIOORGANIC & MEDICINAL CHEMISTRY, vol.26, no.8, pp.1986-1995, 2018 (SCI-Expanded)
Steroidal and non-steroidal aromatase inhibitors target the suppression of estrogen biosynthesis in the treatment of breast cancer. Researchers have increasingly focused on developing non-steroidal derivatives for their potential clinical use avoiding steroidal side-effects.